These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15110086)

  • 1. Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.
    Sadzuka Y; Sugiyama T; Suzuki H; Sawanishi H; Miyamoto K
    Toxicol Lett; 2004 May; 150(3):341-9. PubMed ID: 15110086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glutamate transporter inhibitors on the antitumor activity of doxorubicin.
    Sadzuka Y; Yamashita Y; Sonobe T
    Clin Cancer Res; 2002 Dec; 8(12):3943-7. PubMed ID: 12473610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anserine induced advantage effects on the antitumor activity of doxorubicin.
    Sadzuka Y; Sonobe T
    Food Chem Toxicol; 2007 Jun; 45(6):985-9. PubMed ID: 17240507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
    Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
    Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment.
    Sadzuka Y; Hatakeyama H; Sonobe T
    Int J Pharm; 2010 Jan; 383(1-2):186-91. PubMed ID: 19732815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced efficacy of 1-methyl-3-propyl-7-butylxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia.
    Sadzuka Y; Sugiyama T; Sawanishi H; Miyamoto K
    Cancer Lett; 1999 Apr; 138(1-2):5-11. PubMed ID: 10378767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
    Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
    Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.
    Loadman PM; Bibby MC; Double JA; Al-Shakhaa WM; Duncan R
    Clin Cancer Res; 1999 Nov; 5(11):3682-8. PubMed ID: 10589787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
    Pan C; Cardarelli PM; Nieder MH; Pickford LB; Gangwar S; King DJ; Yarranton GT; Buckman D; Roscoe W; Zhou F; Salles A; Chen TH; Horgan K; Wang YH; Nguyen T; Bebbington CR
    Cancer Res; 2003 Sep; 63(17):5526-31. PubMed ID: 14500390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.
    Dubois V; Dasnois L; Lebtahi K; Collot F; Heylen N; Havaux N; Fernandez AM; Lobl TJ; Oliyai C; Nieder M; Shochat D; Yarranton GT; Trouet A
    Cancer Res; 2002 Apr; 62(8):2327-31. PubMed ID: 11956091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of linalool as a component of Humulus lupulus on doxorubicin-induced antitumor activity.
    Miyashita M; Sadzuka Y
    Food Chem Toxicol; 2013 Mar; 53():174-9. PubMed ID: 23220514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.
    Pastorino F; Di Paolo D; Piccardi F; Nico B; Ribatti D; Daga A; Baio G; Neumaier CE; Brignole C; Loi M; Marimpietri D; Pagnan G; Cilli M; Lepekhin EA; Garde SV; Longhi R; Corti A; Allen TM; Wu JJ; Ponzoni M
    Clin Cancer Res; 2008 Nov; 14(22):7320-9. PubMed ID: 19010847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy.
    de Graaf M; Nevalainen TJ; Scheeren HW; Pinedo HM; Haisma HJ; Boven E
    Biochem Pharmacol; 2004 Dec; 68(11):2273-81. PubMed ID: 15498517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells.
    Sadzuka Y; Egawa Y; Sawanishi H; Miyamoto K; Sonobe T
    Toxicol Lett; 2002 Sep; 135(1-2):137-44. PubMed ID: 12243872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
    Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.
    Sugiyama T; Sadzuka Y
    Biochim Biophys Acta; 2003 Dec; 1653(2):47-59. PubMed ID: 14643924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.